Advanced Accelerator Applications S.A. (AAAP) Given “Buy” Rating at Jefferies Group LLC

Jefferies Group LLC reissued their buy rating on shares of Advanced Accelerator Applications S.A. (NASDAQ:AAAP) in a research report report published on Friday, September 1st. They currently have a $60.00 price target on the stock, up from their previous price target of $50.00.

Other equities analysts have also recently issued research reports about the stock. J P Morgan Chase & Co assumed coverage on shares of Advanced Accelerator Applications in a research note on Thursday, June 15th. They issued an overweight rating and a $50.00 price objective on the stock. JMP Securities upgraded shares of Advanced Accelerator Applications from a market perform rating to an outperform rating and set a $69.00 price objective on the stock in a research note on Thursday, July 27th. Canaccord Genuity set a $47.00 target price on shares of Advanced Accelerator Applications and gave the stock a buy rating in a research note on Thursday, July 27th. TheStreet cut shares of Advanced Accelerator Applications from a c- rating to a d rating in a research note on Wednesday, June 14th. Finally, BidaskClub upgraded shares of Advanced Accelerator Applications from a sell rating to a hold rating in a research note on Friday, June 23rd. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company currently has an average rating of Buy and an average target price of $54.00.

Shares of Advanced Accelerator Applications (NASDAQ AAAP) opened at 56.47 on Friday. The company has a 50 day moving average of $49.73 and a 200-day moving average of $41.10. The firm’s market cap is $2.49 billion. Advanced Accelerator Applications has a one year low of $23.50 and a one year high of $58.98.

Advanced Accelerator Applications (NASDAQ:AAAP) last posted its earnings results on Thursday, August 31st. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.01). Advanced Accelerator Applications had a negative net margin of 33.83% and a negative return on equity of 16.05%. The company had revenue of $40.14 million for the quarter, compared to the consensus estimate of $36.74 million. On average, analysts expect that Advanced Accelerator Applications will post ($0.73) EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://ledgergazette.com/2017/09/17/advanced-accelerator-applications-s-a-aaap-receives-buy-rating-from-jefferies-group-llc.html.

A number of institutional investors and hedge funds have recently made changes to their positions in AAAP. OppenheimerFunds Inc. purchased a new stake in Advanced Accelerator Applications during the 1st quarter valued at approximately $39,009,000. Artisan Partners Limited Partnership purchased a new stake in Advanced Accelerator Applications during the 1st quarter valued at approximately $16,889,000. PointState Capital LP purchased a new position in shares of Advanced Accelerator Applications in the second quarter valued at $5,247,000. Clearbridge Investments LLC purchased a new position in shares of Advanced Accelerator Applications in the first quarter valued at $3,471,000. Finally, Morgan Stanley grew its holdings in shares of Advanced Accelerator Applications by 2,208.1% in the first quarter. Morgan Stanley now owns 72,358 shares of the company’s stock valued at $2,884,000 after purchasing an additional 69,223 shares in the last quarter. 42.00% of the stock is owned by institutional investors and hedge funds.

About Advanced Accelerator Applications

Advanced Accelerator Applications SA is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer.

Analyst Recommendations for Advanced Accelerator Applications (NASDAQ:AAAP)

Receive News & Ratings for Advanced Accelerator Applications S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Accelerator Applications S.A. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply